The 9-valent HPV vaccine is a vaccine to prevent cervical cancer and other cancers associated with high-risk human papillomavirus (HPV) infection. According to the guidance of the World Health Organization (WHO) and other health agencies, the 9-valent cervical cancer vaccine is given to women aged 9 to 45 years and men aged 9 to 26 years.
Cervical cancer is one of the most common cancers in women, with about 90% of cervical cancers associated with high-risk HPV infection. HPV has also been linked to other cancers such as cancer, cancer, and precervical cancer, as well as cancer, mouth, and throat cancers. Studies have shown that vaccination with the 9-valent cervical cancer vaccine can significantly reduce the incidence of these cancers.
Approved by the U.S. Food and Drug Administration (FDA), the 9-valent cervical cancer vaccine can be given to women ages 9 to 45 and men ages 9 to 26. This means that both sexually active women and women with potential risks in the future can benefit from the vaccine. In addition, men can also get the vaccine to reduce the risk of HPV infection and related cancers.
However, the best age for vaccination is before being sexually active. HPV is mainly transmitted through sexual activity, so vaccination provides the best protection before exposure. The cervical cancer vaccine is usually given at the age of 11 to 12 years because studies have shown that the immune system responds better and works best at this time. The schedule is usually two or three doses of the vaccine, depending on age and immune status. If 11 to 12 years of age are missed, other age groups can be vaccinated, but the number and interval of vaccinations may vary.
It is worth mentioning that cervical cancer vaccination is still recommended even if you have been infected with certain HPV types. The vaccine can provide protection against other HPV types, thereby reducing the risk of future infections with other types.
In addition, for women over the age of 26, the doctor may evaluate the individual risk and decide whether the 9-valent cervical cancer vaccine is suitable for vaccination. Therefore, if you are over the age of 26, please consult your doctor for professional advice.
Overall, the 9-valent cervical cancer vaccine is available for women aged 9 to 45 and men aged 9 to 26. Early vaccination provides the best protection, and it is still beneficial to get the vaccine even if you have been infected with certain HPV types. If you are interested in this vaccine, please consult your doctor for more details on the age and schedule of vaccinations. December Creation Incentive Program